1. Identify three principles to include when designing safer processes and systems, and provide a real example of each (preferably healthcare examples).2. Define patient activation. Show how it

*********** ***************** ********************** ** ********** of Safe ****** DesignOne principle for safe ****** is the ******** ** ********* that *** ****** executed by ****** *** ******* of *** staff *** staff ****** ** ******* of ********* *** processes with no ******* *** ********** training level *** environmental ******* (Joshi Ransom **** ***** ****** **** p **** *** ******** *** ********* ** a hospital ******** ****** ** ****** **** ** * *** ******** pharmacist ** ** ** *** * ******* ********** **** **** *** years ** ********** For safety enhancement the ******* ****** be ********** *** *** ***** ***** **** ******* *** ******* ****** ******** ***** **** **** in ******* ***************** ********* ********* ** safe ****** ** standardization *** tools *** ************ **** should ** ************ **** *** respect Industry standards should ** ********** when ********* *** systems Standardized ******* help in *** elimination of ***** and *** minimization ** ************ ********** 2014 * 5) **** *************** *** ** be ************ ** **** ****** ***** systems **** to ** ********** with other technologies *** independent ******* ** a ******** ******* ********* *********** use ********* ****** ******** ***** ********** ******* have ** be ********** ** *** ******* ****** *** *** ********* ** ** ********* *** ********** ******* and procedures ****** ** ** ******* ********* ** *** ******** the system used ** *** ******** ********** is *** ********** **** **** used in *** accounting ********** *** ********* **** have ********** in ****** paymentsSafe ******* should ******** ********* *** designs ****** ********* steps **** add ****** value to *** ****** ********* Reduce ***** ********* ****** complexities (Carayon ** ** **** * *** ** ** **** *** system ***** ** follow * few ***** **** **** *********** steps **** ***** ** * ****** ******* **** ** *** increased *********** for error occurrence ******** assessments should ** ********* ** eliminate *** ***** that **** ****** ********* in * process *** ******** *** very *** ********* **** ********* error ********** *** patient gives the *********** the ************ **** ****** *** the drug ** ** ********** **** **** ****** * ***** ********* ******* *** **** ** *** *********** ** ***** errors *** ****** ** increaseQuestion ** Patient ***************** activation ** *** ********* *** ****** imparted ** ** ********** ** ****** their ****** and care Patient ********** also ******** *** ********** ******** ** those ****** **** manage their care (Earp ****** ***** ****** **** * **** Patient ********** ** mostly ****** *** ***** individuals **** **** ********** **** ******* long-term **** Patient activation has ****** ****** ********** ** *** users as **** ** ******* care ***************** activation ** ******** ******* Patient ********** ******* ***** *** is * ************** *********** approach ******** ** ****** the ****** ********** and ********* of ******* ********** ************ *** ***** ********** ********* identify *** ****** of patient ********** on *** ******* ******** ** ** **** * ** ******* Pam ********* weaknesses ** the ****** *** ********** Those procedures **** *** *** ******* *** the patient *** ********** The measurement ***** ******** *** ********* ******** of *** ******* Once *** ******* ***** of activation ** identified measures *** ** *********** to ******** their ************ ****** (Greene et ** **** * **** *** ***** ** *** ************** ** those care ***** that *** important ** *** ******* instead of *** ************************** * ********** T * **************** * * ***** * S ********* * ****** * & Gurses * * ****** Human factors ******* approach ** ********** ******* *** ******* safety ******* ********** 45(1) ********* * * French * & ****** * * (2014) ******* ******** for ****** **** ******** ********** *** ********* patient-centered **** ******* *** ***** ***** ************** * ******* J * Sacks * ******* * ***** Parrotta C * (2015) When ******* activation ****** ****** ****** ******** and ***** ****** *** ****** ******* ***** ************ * ****** * * **** D * ***** ****** * * ****** *** ********** ******* ***** ****** ******** *** ***** Chicago *** Health ************** PressLindsay A ******* * * ********* D * ********* * & Asch * * (2018) ******* Activation ******* ** a Potential ****** *** ******* ** ****** Care ****** ****** ***** ** US High-Cost Patients ******* of ******* ******** ******** ************ * * ****** Research ********** for the ******** ** things IEEE ******** of Things ******* **** *****

Click here to download attached files: Safe Systems.docx